Cargando…
A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
The present study investigated whether a concentration of serum thymidine kinase 1 (STK1p) could be used to distinguish between healthy individuals, patients with colorectal benign tumors and individuals with colorectal cancer (CRC). The effectiveness of surgery on patients with CRC was monitored. A...
Autores principales: | Dang, Li, Ma, Hongbo, Hei, Ailian, Xu, Shuai, Zhou, Ji, He, Ellen, Skog, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087469/ https://www.ncbi.nlm.nih.gov/pubmed/32257201 http://dx.doi.org/10.3892/mco.2020.2002 |
Ejemplares similares
-
Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis
por: Ma, Hongbo, et al.
Publicado: (2021) -
Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
por: Fang, Yujing, et al.
Publicado: (2023) -
Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery
por: Wang, Xiangbin, et al.
Publicado: (2023) -
Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
por: Wang, Naining, et al.
Publicado: (2001) -
Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay
por: Chen, Zhi Heng, et al.
Publicado: (2011)